事業提携・ライセンシング・投資・M&A動向:August 2013(製薬業界)...市場調査レポートについてご紹介

【英文タイトル】Partnerships, Licensing, Investments and M&A Deals and Trends for August 2013 in Pharmaceuticals

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 9
2 Pharmaceuticals & Healthcare, Global, Deal Summary 12
2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, August 2013 12
2.2 Pharmaceuticals & Healthcare, Global, Major Deals, August 2013 14
2.2.1 Amgen Receives Antitrust Approval to Acquire Onyx Pharma for up to US$10.4 Billion 14
2.2.2 Celgene Completes Public Offering of Notes for US$1.5 Billion 15
2.2.3 Sanofi Prices Public Offering of Bonds Due 2020 for US$1.3 Billion 16
2.2.4 Akorn to Acquire Hi-Tech Pharmacal for US$640 Million 16
2.2.5 Pharmstandard Completes Acquisition of Bever Pharma for US$590 Million 17
2.3 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, August 2013 18
2.4 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, August 2013 19
3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type 20
3.1 Pharmaceuticals & Healthcare, Global, M&A, August 2013 20
3.1.1 Top M&A Deals in August 2013 21
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy Area, March 2013 – August 2013 22
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, August 2013 24
3.2.1 Top Equity Offering Deals in August 2013 26
3.2.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, March 2013 – August 2013 27
3.3 Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital Deals, August 2013 29
3.3.1 Top PE/VC Deals in August 2013 30
3.3.2 Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area, August 2013 31
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, August 2013 33
3.3.4 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, March 2013-August 2013 35
3.3.5 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, March 2013-August 2013 36
4 Pharmaceuticals & Healthcare, Global, Partnership Deals, August 2013 37
4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, August 2013 37
4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, March 2013 – August 2013 39
4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Values (US$ m), August 2013 41
4.3.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals by Payment Mode, August 2013 42
4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), March 2013 – August 2013 43
4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Number Of Deals, March 2013 – August 2013 45
4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Deal Values (US$ m), March 2013 – August 2013 46
4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), March 2013 – August 2013 48
5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, August 2013 50
5.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, August 2013 50
5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), August 2013 52
5.2.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Deal Value, August 2013 54
5.2.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, August 2013 54
5.2.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Total Milestone Payment, August 2013 54
5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Values (US$ m), March 2013 – August 2013 55
5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payments and Milestone Payments (US$ m), March 2013 – August 2013 57
5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Values (US$ m), March 2013 – August 2013 59
5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Upfront Payments and Milestone Payments (US$ m), March 2013 – August 2013 61
6 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 63
6.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, August 2013 63
6.1.1 Oncology – Deals of the Month 65
6.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, August 2013 67
6.2.1 Central Nervous System – Deals of the Month 68
6.3 Pharmaceuticals & Healthcare, Global, Immunology Deals, August 2013 70
6.3.1 Immunology – Deal of the Month 71
6.4 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, August 2013 72
6.4.1 Infectious Diseases – Deals of the Month 74
6.5 Pharmaceuticals & Healthcare, Global, Metabolic Disorder Deals, August 2013 75
6.5.1 Metabolic Disorders – Deal of the Month 76
6.6 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, August 2013 77
6.6.1 Cardiovascular – Deal of the Month 78
6.7 Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals, August 2013 79
6.7.1 Gastrointestinal – Deal of the Month 80
7 Deal Summary by Geography 81
7.1 Pharmaceuticals & Healthcare, North America Deals, August 2013 81
7.1.1 North America – Deals of the Month 82
7.2 Pharmaceuticals & Healthcare, Europe, Deals, August 2013 84
7.2.1 Europe – Deals of the Month 85
7.3 Pharmaceuticals & Healthcare, Asia-Pacific, Regional Deals, August 2013 87
7.3.1 Asia-Pacific – Deals of the Month 88
7.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, August 2013 90
7.4.1 Rest of the World – Deals of the Month 91
8 Pharmaceuticals & Healthcare, Global, Top Financial Advisors 92
8.1 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, March 2013 – August 2013 92
8.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, March 2013 – August 2013 94
9 Further Information 96
9.1 Methodology 96
9.2 About GlobalData 97
9.3 Disclosure information 98
9.4 Disclaimer 98


【レポート販売概要】

■ タイトル:事業提携・ライセンシング・投資・M&A動向:August 2013(製薬業界)
■ 英文:Partnerships, Licensing, Investments and M&A Deals and Trends for August 2013 in Pharmaceuticals
■ 発行日:2013年9月30日
■ 調査会社:GlobalData
■ 商品コード:GDATA403162245
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。